Stay updated with breaking news from Leukocytes Reduced. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Hemanext ONE has been granted marketing authorization for commercial distribution via the De Novo process by the U.S. Food and Drug Administration (FDA).
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
/PRNewswire/ -- Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, today announced the successful first close of its...
/PRNewswire/ -- Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, today announced the successful first close of its...
Press release content from PR Newswire. The AP news staff was not involved in its creation.